Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Pharmaceutical Statistics|June 27, 2022
Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomesGaohong Dong, Bo Huang, Johan Verbeeck, et al.Transplantation|August 25, 2011
Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantationAndreas Zuckermann, Jose M Arizon, Gaohong Dong, et al.Journal of Transplantation|February 2, 2012
Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized TrialAndreas Zuckermann, Shoei-Shen Wang, Heather Ross, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 3, 2014
Fibrosis progression in maintenance liver transplant patients with hepatitis C recurrence: a randomised study of everolimus vs. calcineurin inhibitorsFederico G Villamil, Adrian C Gadano, Fernanda Zingale, et al.JACC. Heart Failure|March 14, 2014
Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trialJon A Kobashigawa, Daniel F Pauly, Randall C Starling, et al.Transplantation|July 8, 2015
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter StudyLutz Fischer, Faouzi Saliba, Gernot M Kaiser, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|April 5, 2012
Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantationRobert M Langer, Ronald Hené, Stefan Vitko, et al.Pageof 3